BELOW Copy and Paste from Quarterly Ann:………JUST A REMINDER……..
Resource Extension DrillingSince the beginning of the year, two rigs have been dedicated to testing for structural extensions and new veins in the mine area, which hosts a current Inferred Resource of 2.23Moz of gold at a grade of 7.8g/t.In mine drilling during the June quarter focused predominantly on the definition and extension of the Tyson vein discovery and the Shaft 3 area.
See ASX release dated 3 May 2022 for further details.Highlights from the drilling included:•
7.8m @ 17.0g/t gold from 335.3m in hole AUDD0266•
1.6m @ 73.2g/t gold from 37.9m in hole AUDD0249•
1.2m @ 37.5g/t gold from 284.5m in hole AUDD0266•
0.3m @ 134.0g/t gold from 422.8m in hole AUDD0253•
1.3m @ 11.7g/t gold from 347.8 in hole AUDD0266•
2.5m @ 6.7g/t gold from 273m in hole AUDD0264•
5.6m @ 5.0g/t gold from 441.9m in hole AUDD0266•
8.1m @ 3.3g/t gold from 615.8m in hole AUDD0260
FURTHER RESULTS are expected from Tyson and the Shaft 3 areas during the SEPTEMBER quarter.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
BELOW Copy and Paste from Quarterly Ann:………JUST A...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFM (ASX) to my watchlist
(20min delay)
|
|||||
Last
81.0¢ |
Change
-0.020(2.41%) |
Mkt cap ! $386.9M |
Open | High | Low | Value | Volume |
82.0¢ | 82.5¢ | 79.5¢ | $606.2K | 751.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 38622 | 80.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
81.0¢ | 30391 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 28967 | 0.805 |
8 | 61326 | 0.800 |
6 | 52041 | 0.795 |
9 | 84107 | 0.790 |
7 | 28995 | 0.785 |
Price($) | Vol. | No. |
---|---|---|
0.810 | 38303 | 8 |
0.815 | 31283 | 7 |
0.820 | 48288 | 8 |
0.825 | 22600 | 5 |
0.830 | 86798 | 7 |
Last trade - 14.52pm 15/07/2024 (20 minute delay) ? |
Featured News
FFM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online